BioArctic gets approval to initiate Leqembi subcutaneous treatment in China
BioArctic AB says Leqembi’s subcutaneous formulation has been approved for initiation treatment in China.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.